Preoperative serum concentration of hCGβ as a prognostic factor in ovarian cancer

International Journal of Cancer

Volumn 95, Issue 5, 2001, Pages 313-316

  Vartiainen, Juhani ^a   Lehtovirta, Pentti ^a   Finne, Patrik ^a   Stenman, Ulf Håkan ^a   Alfthan, Henrik ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Department of Clinical Chemistry ^*  (Finland)

Author keywords

Chorionic gonadotropin, beta subunit; Ovarian neoplasms; Prognosis

Indexed keywords

APROTININ; CA 125 ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CANCER; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FLUOROIMMUNOASSAY; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035922048     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010920)95:5<313::AID-IJC1054>3.0.CO;2-Q     Document Type: Article

References (34)

1. Estimation of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden
2. Cancer statistics, 1994
3. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic cancer registries
4. Cancer statistics, 1999
5. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer
6. Ovarian carcinoma: A multivariate analysis of prognostic factors
7. Surgery in the treatment of patients with advanced ovarian cancer
8. Primary treatment of epithelial ovarian malignancies
9. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: A prospective study
10. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer
11. CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer
12. Prognostic value of pre- and prostoperative serum CA 125 levels in ovarian cancer: New aspects and multivariate analysis
13. Tumor-associated trypsin inhibitor (TATI): Comparison with CA125 as a preoperative prognostic indicator in advanved ovarian cancer
14. Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma
15. Vascular endothelial growth factor serum concentrations in ovarian cancer
16. Ectopic production of human chorionic gonadotrophin by neoplasms
17. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms
18. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer
19. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease
20. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers
21. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance
22. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix
23. Choriogonadotropin and its beta subunit separated by hydrophobic- interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays
24. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women
25. Immunochemical demonstration of an ovarian cancer-associated urinary peptide
26. Nonparametric estimation from incomplete observations
27. Regression models and life tables
28. Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse
29. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer
30. Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in stage III epithelial ovarian cancer
31. The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines
32. Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells
33. Human chorionic gonadotropin and free beta subunits stimulate phospholipid methylation in intact rat Leydig cells